11-beta-HSD1 inhibitors (Bristol-Myers Squibb Co)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name11-beta-HSD1 inhibitors (Bristol-Myers Squibb Co)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Pituitary ACTH Hypersecretion
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2Pituitary ACTH Hypersecretion

Other Information

ATC CodeN/A
Related LinksN/A